Floatz logo

Allopurinol

Tumor Lysis Syndrome

Menarini GroupSmall moleculePhase 3Dormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Tumor Lysis Syndrome cohort.

Asset / SponsorPhaseRating
Rasburicase
M.D. Anderson Cancer Center
Phase 4A
Pegloticase
M.D. Anderson Cancer Center
Phase 4BB
Febuxostat
Menarini Group
Phase 3BB

Same molecule, other indications

Allopurinol is also rated in:

manic bipolar affective disorderDormant
BB
Indicative ·
70 / 100
View asset →
Untreated Adult Acute Lymphoblastic LeukemiaDormant
BB
Indicative ·
68 / 100
View asset →
essential hypertensionDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →